Ignite Creation Date:
2024-05-06 @ 2:07 PM
Last Modification Date:
2024-10-26 @ 1:25 PM
Study NCT ID:
NCT04222465
Status:
COMPLETED
Last Update Posted:
2021-10-26
First Post:
2020-01-07
Brief Title:
Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA12 Mutations in Newly Diagnosed Advanced Ovarian Cancer Patients
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Organization Data
Organization:
AstraZeneca
Class:
INDUSTRY
Study ID:
D0817R00018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AstraZeneca
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None